{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"The Founder's Dilemma: Why Great Science Isn't Enough!","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/ab5da97a\"></iframe>","width":"100%","height":180,"duration":2566,"description":"Katrina Rogers has spent her career helping biotech innovators navigate one of the toughest journeys in business: turning scientific breakthroughs into successful companies. In this episode, she shares why great science alone rarely guarantees success, the hidden challenges that cause promising startups to stall, and the critical role advisors, investors, and strategic networks play in bringing new therapies to market. From fundraising and founder psychology to commercialization and leadership, Katrina offers an inside look at what it really takes to move a biotech company from discovery to exit—and why the biggest obstacles are often the ones founders never see coming.Chapters:00:00 The Loneliness and Rewards of Founding01:00 Navigating the Life Sciences Ecosystem09:57 The Role of Advisors in Drug Development19:02 Challenges in Fundraising and Pitching21:20 Building a Convincing Business Case22:35 Preparing Founders for Success25:26 The Importance of Education in Entrepreneurship27:12 Understanding Founder DNA and Team Dynamics30:16 Trust and Relationships in Investment31:35 Crafting the Perfect Pitch35:32 Networking and Community Building39:08 The Role of Mentorship in Capital Readiness41:05 Future Endeavors and Learning OpportunitiesGuest Information:Guest's Name:  Katrina RogersGuest's Linkedin: https://www.linkedin.com/in/katrinarogers/Company / Affiliation: Katrina Rogers Consulting https://krogersconsulting.com/Guest's Bio: Katrina Rogers is the Founder and CEO of Katrina Rogers Consulting, where she advises biotech and life sciences companies on strategy, drug development, commercialization, and organizational growth. With more than 20 years of experience across pharmaceutical research, operations, and business leadership, she helps founders and executives navigate complex challenges, build high-performing organizations, and bring innovative therapies to market. An analytical chemist by training, Katrina is recognized for her ability to bridge science,...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}